ReviewImmunoTargets and therapy2021
Anti-CD52 Therapy for Multiple Sclerosis: An Update in the COVID Era.
Kaja Kasarello et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ReviewImmunoTargets and therapy2021
Kaja Kasarello et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.